{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:16:10Z","timestamp":1790871370096,"version":"4.1.0"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2011,7,8]],"date-time":"2011-07-08T00:00:00Z","timestamp":1310083200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0022110","type":"journal-article","created":{"date-parts":[[2011,7,8]],"date-time":"2011-07-08T21:12:31Z","timestamp":1310159551000},"page":"e22110","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":92,"title":["Aberrant DNA Methylation Is Associated with Disease Progression, Resistance to Imatinib and Shortened Survival in Chronic Myelogenous Leukemia"],"prefix":"10.1371","volume":"6","author":[{"given":"Jaroslav","family":"Jelinek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vazganush","family":"Gharibyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos R. H.","family":"Estecio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimie","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woonbok","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nianxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoudan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagop M.","family":"Kantarjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge E.","family":"Cortes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre J.","family":"Issa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,7,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/j.seminoncol.2005.07.003","article-title":"Epigenetic changes in solid and hematopoietic tumors.","volume":"32","author":"M Toyota","year":"2005","journal-title":"Semin Oncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1182\/blood-2007-11-126227","article-title":"Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse.","volume":"112","author":"H Kroeger","year":"2008","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/leu.2008.130","article-title":"Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia.","volume":"22","author":"SQ Kuang","year":"2008","journal-title":"Leukemia"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1158\/0008-5472.CAN-03-2870","article-title":"Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets.","volume":"64","author":"LJ Rush","year":"2004","journal-title":"Cancer Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1158\/0008-5472.CAN-05-3712","article-title":"CpG island methylation and expression of the secreted frizzled-related protein gene family in chronic lymphocytic leukemia.","volume":"66","author":"TH Liu","year":"2006","journal-title":"Cancer Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/blood-2009-07-232868","article-title":"Differential genome-wide array-based methylation profiles in prognostic subsets of chronic lymphocytic leukemia.","volume":"115","author":"M Kanduri","year":"2010","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1182\/blood-2008-06-163246","article-title":"Aberrant DNA methylation is a dominant mechanism in MDS progression to AML.","volume":"113","author":"Y Jiang","year":"2009","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1200\/JCO.2009.23.4781","article-title":"DNA methylation predicts survival and response to therapy in patients with myelodysplastic syndromes.","volume":"28","author":"L Shen","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"9312","DOI":"10.1073\/pnas.85.23.9312","article-title":"Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr\/abl protein.","volume":"85","author":"GQ Daley","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrclinonc.2009.112","article-title":"Imatinib and beyond\u2013exploring the full potential of targeted therapy for CML.","volume":"6","author":"A Quintas-Cardama","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1182\/blood.V77.11.2431.2431","article-title":"Abnormal methylation of the calcitonin gene marks progression of chronic myelogenous leukemia.","volume":"77","author":"BD Nelkin","year":"1991","journal-title":"Blood"},{"key":"ref12","first-page":"973","article-title":"The estrogen receptor CpG island is methylated in most hematopoietic neoplasms.","volume":"56","author":"JP Issa","year":"1996","journal-title":"Cancer Res"},{"key":"ref13","first-page":"1678","article-title":"HIC1 hypermethylation is a late event in hematopoietic neoplasms.","volume":"57","author":"JP Issa","year":"1997","journal-title":"Cancer Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1182\/blood.V95.9.2990.009k08_2990_2992","article-title":"Quantitative measure of c-abl and p15 methylation in chronic myelogenous leukemia: biological implications.","volume":"95","author":"TT Nguyen","year":"2000","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1200\/JCO.2003.08.166","article-title":"Cadherin-13, a mediator of calcium-dependent cell-cell adhesion, is silenced by methylation in chronic myeloid leukemia and correlates with pretreatment risk profile and cytogenetic response to interferon alfa.","volume":"21","author":"J Roman-Gomez","year":"2003","journal-title":"J Clin Oncol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.1158\/1078-0432.CCR-07-0919","article-title":"Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosis.","volume":"13","author":"G Strathdee","year":"2007","journal-title":"Clin Cancer Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"10722","DOI":"10.1073\/pnas.91.22.10722","article-title":"Progressive de novo DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia.","volume":"91","author":"M Zion","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.leukres.2008.11.013","article-title":"sFRP1 promoter methylation is associated with persistent Philadelphia chromosome in chronic myeloid leukemia.","volume":"33","author":"M Pehlivan","year":"2009","journal-title":"Leuk Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.leukres.2009.01.003","article-title":"Methylation status of RASSF1A in patients with chronic myeloid leukemia.","volume":"33","author":"A Avramouli","year":"2009","journal-title":"Leuk Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1476-4598-9-44","article-title":"A genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers.","volume":"9","author":"T Dunwell","year":"2010","journal-title":"Mol Cancer"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"319a","DOI":"10.1182\/blood.V104.11.1126.1126","article-title":"Identification of 41 novel promoter-associated CpG islands methylated in leukemias [Meeting Abstract].","volume":"104","author":"J Jelinek","year":"2004","journal-title":"Blood"},{"key":"ref22","first-page":"660A","article-title":"Methylation at CpG islands of tumor-associated genes in polycythemia vera [Meeting Abstract].","volume":"102","author":"J Jelinek","year":"2003","journal-title":"Blood"},{"key":"ref23","first-page":"837","article-title":"Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies.","volume":"57","author":"JG Herman","year":"1997","journal-title":"Cancer Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1182\/blood.V45.3.321.321","article-title":"Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome.","volume":"45","author":"CB Lozzio","year":"1975","journal-title":"Blood"},{"key":"ref25","first-page":"2307","article-title":"Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification.","volume":"59","author":"M Toyota","year":"1999","journal-title":"Cancer Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1101\/gr.6417007","article-title":"High-throughput methylation profiling by MCA coupled to CpG island microarray.","volume":"17","author":"MR Estecio","year":"2007","journal-title":"Genome Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cell.2006.02.043","article-title":"Control of developmental regulators by Polycomb in human embryonic stem cells.","volume":"125","author":"TI Lee","year":"2006","journal-title":"Cell"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"6062","DOI":"10.1073\/pnas.0400782101","article-title":"A gene atlas of the mouse and human protein-encoding transcriptomes.","volume":"101","author":"AI Su","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1200\/JCO.2005.11.981","article-title":"Phase II study of low-dose decitabine in patients with chronic myelogenous leukemia resistant to imatinib mesylate.","volume":"23","author":"JP Issa","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1038\/ng1909","article-title":"DNA methylation profiling of human chromosomes 6, 20 and 22.","volume":"38","author":"F Eckhardt","year":"2006","journal-title":"Nat Genet"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1093\/nar\/gnh032","article-title":"A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements.","volume":"32","author":"AS Yang","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1158\/0008-5472.CAN-06-3093","article-title":"RIL, a LIM gene on 5q31, is silenced by methylation in cancer and sensitizes cancer cells to apoptosis.","volume":"67","author":"YA Boumber","year":"2007","journal-title":"Cancer Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/07357900802406319","article-title":"PDLIM4, an actin binding protein, suppresses prostate cancer cell growth.","volume":"27","author":"DK Vanaja","year":"2009","journal-title":"Cancer Invest"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1083\/jcb.200810155","article-title":"Reversion-induced LIM interaction with Src reveals a novel Src inactivation cycle.","volume":"184","author":"Y Zhang","year":"2009","journal-title":"J Cell Biol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e2079","DOI":"10.1371\/journal.pone.0002079","article-title":"Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling.","volume":"3","author":"W Chung","year":"2008","journal-title":"PLoS One"},{"key":"ref36","first-page":"722","article-title":"Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B.","volume":"56","author":"JG Herman","year":"1996","journal-title":"Cancer Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1096\/fj.09-143370","article-title":"Role of the nucleoplasmin 2 C-terminal domain in the formation of nucleolus-like bodies in mouse oocytes.","volume":"24","author":"A Inoue","year":"2010","journal-title":"Faseb J"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1101\/gr.091447.109","article-title":"Genome-wide screen of promoter methylation identifies novel markers in melanoma.","volume":"19","author":"Y Koga","year":"2009","journal-title":"Genome Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1186\/bcr1762","article-title":"Correlation between CpG methylation profiles and hormone receptor status in breast cancers.","volume":"9","author":"W Feng","year":"2007","journal-title":"Breast Cancer Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/CMR.0b013e32832b274e","article-title":"CpG island methylation profiling in human melanoma cell lines.","volume":"19","author":"CS Tellez","year":"2009","journal-title":"Melanoma Research"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/j.1872-034X.2007.00141.x","article-title":"Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomas.","volume":"37","author":"Y Kondo","year":"2007","journal-title":"Hepatol Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1158\/1078-0432.CCR-0825-03","article-title":"DNA methylation in serum and tumors of cervical cancer patients.","volume":"10","author":"A Widschwendter","year":"2004","journal-title":"Clin Cancer Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00432-003-0451-9","article-title":"Cloning, expression, and mutation analysis of NOR1, a novel human gene down-regulated in HNE1 nasopharyngeal carcinoma cell line.","volume":"129","author":"X Nie","year":"2003","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"32332","DOI":"10.1074\/jbc.M504246200","article-title":"Isolation and functional characterization of a novel organic solute carrier protein, hOSCP1.","volume":"280","author":"Y Kobayashi","year":"2005","journal-title":"J Biol Chem"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"8681","DOI":"10.1073\/pnas.96.15.8681","article-title":"CpG island methylator phenotype in colorectal cancer.","volume":"96","author":"M Toyota","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0065-230X(08)60702-2","article-title":"Alterations in DNA methylation: a fundamental aspect of neoplasia.","volume":"72","author":"SB Baylin","year":"1998","journal-title":"Adv Cancer Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"e399","DOI":"10.1371\/journal.pone.0000399","article-title":"LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability.","volume":"2","author":"MR Estecio","year":"2007","journal-title":"PLoS ONE"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.1038\/sj.onc.1208866","article-title":"Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense\/antisense transcription and marks the progression of chronic myeloid leukemia.","volume":"24","author":"J Roman-Gomez","year":"2005","journal-title":"Oncogene"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.leukres.2007.07.021","article-title":"Repetitive DNA hypomethylation in the advanced phase of chronic myeloid leukemia.","volume":"32","author":"J Roman-Gomez","year":"2008","journal-title":"Leuk Res"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11523-008-0100-y","article-title":"Treatment selection after imatinib resistance in chronic myeloid leukemia.","volume":"4","author":"E Jabbour","year":"2009","journal-title":"Target Oncol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/cncr.22470","article-title":"Phase II study of low-dose decitabine in combination with imatinib mesylate in patients with accelerated or myeloid blastic phase of chronic myelogenous leukemia.","volume":"109","author":"Y Oki","year":"2007","journal-title":"Cancer"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0022110","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T06:17:05Z","timestamp":1592720225000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0022110"}},"subtitle":[],"editor":[{"given":"Felipe","family":"Prosper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,7,8]]},"references-count":51,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2011,7,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0022110","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,8]]}}}